Hemispherian is a startup based in Norway, 1 tracked investor.
Hemispherian is a startup founded in 2023 based in Norway. Brouky records 1 investor associated with the company.
Hemispherian is a clinical-stage pharmaceutical company developing novel small molecule drugs targeting the TET2 enzyme to treat aggressive cancers such as glioblastoma by restoring cancer cells' normal epigenetic complement and triggering DNA damage response.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.